149 related articles for article (PubMed ID: 6860375)
1. Decreased complement mediated binding of antibody/3H-dsDNA immune complexes to the red blood cells of patients with systemic lupus erythematosus, rheumatoid arthritis, and hematologic malignancies.
Taylor RP; Horgan C; Buschbacher R; Brunner CM; Hess CE; O'Brien WM; Wanebo HJ
Arthritis Rheum; 1983 Jun; 26(6):736-44. PubMed ID: 6860375
[TBL] [Abstract][Full Text] [Related]
2. Studies on the kinetics of binding of complement-fixing dsDNA/anti-dsDNA immune complexes to the red blood cells of normal individuals and patients with systemic lupus erythematosus.
Horgan C; Taylor RP
Arthritis Rheum; 1984 Mar; 27(3):320-9. PubMed ID: 6546694
[TBL] [Abstract][Full Text] [Related]
3. Interaction between rheumatoid factor and antibody/DNA complexes: enhancement of complement fixation.
Birchmore DA; Taylor RP; Waller SJ; Davis JS; Morley KW
Arthritis Rheum; 1981 Mar; 24(3):527-33. PubMed ID: 7213431
[TBL] [Abstract][Full Text] [Related]
4. Dynamics of interaction between complement-fixing antibody/dsDNA immune complexes and erythrocytes. In vitro studies and potential general applications to clinical immune complex testing.
Taylor RP; Horgan C; Hooper M; Burge J
J Clin Invest; 1985 Jan; 75(1):102-11. PubMed ID: 3917462
[TBL] [Abstract][Full Text] [Related]
5. The interaction of antibody/DNA immune complexes with complement. Influence of antibody class and DNA conformation.
Taylor RP; Edberg JC; Kujala GA; Sloman AJ; Wilson CC; Cronin ME
Arthritis Rheum; 1987 Feb; 30(2):176-85. PubMed ID: 3493781
[TBL] [Abstract][Full Text] [Related]
6. Quantitative determination of anti-dsDNA antibodies and antibody/dsDNA stoichiometries in prepared, soluble complement-fixing antibody/dsDNA immune complexes.
Taylor RP; Horgan C
Mol Immunol; 1984 Oct; 21(10):853-62. PubMed ID: 6334233
[TBL] [Abstract][Full Text] [Related]
7. Quantitative studies of the interaction of 3H-dsDNA/anti-DNA immune complexes with complement: comparison and evaluation of the Raji cell, the solution phase C1Q, and the red blood cell linked complement fixation radioimmunoassays.
Taylor RP; Andrews BS; Morley KW; Conlon T
Rheumatol Int; 1981; 1(1):29-34. PubMed ID: 6981180
[TBL] [Abstract][Full Text] [Related]
8. DNA/anti-DNA complexes: correlation of size and complement fixation.
Waller SJ; Taylor RP; Wright EL; Morley KW; Johns M
Arthritis Rheum; 1981 May; 24(5):651-7. PubMed ID: 7236322
[TBL] [Abstract][Full Text] [Related]
9. Stability of DNA/ANTI-DNA complexes. IV. Complement fixation.
Pedersen SE; Taylor RP; Morley KW; Wright EL
J Immunol Methods; 1980; 38(3-4):269-80. PubMed ID: 7440976
[TBL] [Abstract][Full Text] [Related]
10. The complement-mediated binding of soluble antibody/dsDNA immune complexes to human neutrophils.
Taylor RP; Burge J; Horgan C; Shasby DM
J Immunol; 1983 Jun; 130(6):2656-62. PubMed ID: 6854016
[TBL] [Abstract][Full Text] [Related]
11. Immune complexes and other laboratory features of pleural effusions: a comparison of rheumatoid arthritis, systemic lupus erythematosus, and other diseases.
Halla JT; Schrohenloher RE; Volanakis JE
Ann Intern Med; 1980 Jun; 92(6):748-52. PubMed ID: 7387017
[TBL] [Abstract][Full Text] [Related]
12. Complement receptor (CR1) deficiency in erythrocytes from patients with systemic lupus erythematosus.
Iida K; Mornaghi R; Nussenzweig V
J Exp Med; 1982 May; 155(5):1427-38. PubMed ID: 6978375
[TBL] [Abstract][Full Text] [Related]
13. An enzyme based assay for the measurement of complement mediated binding of immune complexes to red blood cells.
Rafnar BO; Traustadóttir KH; Sigfússon A; Arason GJ; Valdimarsson H; Erlendsson K
J Immunol Methods; 1998 Feb; 211(1-2):171-81. PubMed ID: 9617841
[TBL] [Abstract][Full Text] [Related]
14. The change in C3b receptors on erythrocytes from patients with systemic lupus erythematosus.
Yoshida K; Yukiyama Y; Hirose S; Miyamoto T
Clin Exp Immunol; 1985 Jun; 60(3):613-21. PubMed ID: 3160514
[TBL] [Abstract][Full Text] [Related]
15. [Detection of circulating immune complexes in patients with lupus erythematosus, viral hepatitis and rheumatoid arthritis using radioactive marked C1q].
Nydegger U; Lambert PH; Miescher PA
Verh Dtsch Ges Inn Med; 1974; 80():1575-7. PubMed ID: 4217986
[No Abstract] [Full Text] [Related]
16. Altered glycosylation of complexed native IgG molecules is associated with disease activity of systemic lupus erythematosus.
Sjöwall C; Zapf J; von Löhneysen S; Magorivska I; Biermann M; Janko C; Winkler S; Bilyy R; Schett G; Herrmann M; Muñoz LE
Lupus; 2015 May; 24(6):569-81. PubMed ID: 25389233
[TBL] [Abstract][Full Text] [Related]
17. Pleural fluid complement in systemic lupus erythematosus and rheumatoid arthritis.
Hunder GG; McDuffie FC; Hepper NG
Ann Intern Med; 1972 Mar; 76(3):357-63. PubMed ID: 5015911
[No Abstract] [Full Text] [Related]
18. The kinetics of [3H]-dsDNA/anti-DNA immune complex formation, binding by red blood cells, and release into serum: effect of DNA molecular weight and conditions of antibody excess.
Horgan C; Burge J; Crawford L; Taylor RP
J Immunol; 1984 Oct; 133(4):2079-84. PubMed ID: 6332147
[TBL] [Abstract][Full Text] [Related]
19. Proceedings: Systemic lupus erythematosus and rheumatoid arthritis.
Hughes GR
J Clin Pathol; 1976 Jan; 29(1):84. PubMed ID: 1249256
[No Abstract] [Full Text] [Related]
20. [Study of DNA-binding activity of blood serum in systemic lupus erythematosus, rheumatoid arthritis and crossing syndromes].
Matveĭkov GP; Podgorodnichenko VK; Koshelev VK; Nazarov IuM
Ter Arkh; 1976; 48(11):36-40. PubMed ID: 1021891
[No Abstract] [Full Text] [Related]
[Next] [New Search]
